Determinants for Acceptance of COVID-19 Vaccine in Nigeria

Background: The coronavirus disease 2019 (COVID-19) pandemic heralded an unprecedented race to the development of several vaccine candidates at record speeds never seen in global health. Within nine months, Pfizer-BioNTech’s COVID-19 vaccine was approved by the United States FDA. Unfortunately, whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Eze, Ugochukwu A, Ndoh, Kingsley I, Ibisola, Babalola A, Onwuliri, Chinemerem D, Osiyemi, Adenekan, Ude, Nnamdi, Chime, Amalachukwu A, Ogbor, Eric O, Alao, Adegboyega O, Abdullahi, Ashiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Preventive Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695669/
https://www.ncbi.nlm.nih.gov/pubmed/34963828
http://dx.doi.org/10.7759/cureus.19801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695669/
https://www.ncbi.nlm.nih.gov/pubmed/34963828
http://dx.doi.org/10.7759/cureus.19801

Ejemplares similares